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1. Introduction 
AF is a major concern in general population worldwide. Every year, 3 million suffer from 
AF related stroke, 1.5 million die from AF related stroke within a year, and 1 million are 
severely disabled by AF related stroke. Only 1% of AF patients underwent a treatment such 
as ablation or AF surgery. 99% remain as they are or prophylactic anticoagulation 
medication only. The reason why is due to the limitation in diagnostic mapping and 
ablation treatment. Incomplete, vague and fragmented maps give us incomplete AF 
information, and lead to incomplete cure chance. Standard 12-lead ECG, which composed of 
6 bipolar Einthoven limb leads and 6 unipolar Wilson pre-cordial leads, are used for more 
than 100 years giving us the information about rhythm, electric axis, activation sequence, 
and repolarization pattern. However, the F wave information of standard ECG signals 
during AF has limitation that only a few signals are available to show whether AF or not, or 
little information of source or location of its origin. The exact location of source origin and 
propagation route or pattern of reentry is too difficult to be elucidated by conventional low-
sensitive ECG method due to its very weak signal amplitude of F-wave. Therefore, in order 
to manage AF successfully, we should get detailed information of AF activity in atrium 
using a high sensitive mapping methodology. Accurate mapping is the essential to 
successful treatment of arrhythmia. Endocardial mapping techniques for AF are now well 
developed and its accuracy reached high to treat AF effectively, however, they demand 
invasiveness, moderate costs and selection of patients. They are not suitable for mass 
screening to general population yet. Non-invasive mapping for AF is still far from bed-side 
due to its insufficient information of AF, not enough to detect F wave and to make a 
sufficient map to treat AF. According to the recently updated worldwide survey on AF 
ablation by Cappato et al. [1] in 2010, anti-arrhythmic drug-off success rate and overall 
success rate are 75% and 83% for paroxysmal AF, 65% and 75% for persistent AF, and 63% 
and 72% for long-standing persistent AF. Major complications were reported 4.5% from 
catheter ablation for AF. They reported that CARTO-guided left atrial circumferential 
ablation (48% of all treated patients) and Lasso-guided ostial electric disconnection (27% of 
all treated patients) were the most commonly used techniques for AF treatment. To improve 
the success rate, exact cardiac mapping of AF is essential. 
In this chapter, we described several topics of cardiac map, such as history, importance, 
composition, classification, basic principle, clinically available maps, and my study work, 
Magnetocardiography Action Potential Activity mapping for AF and future frontiers. 
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2. History of cardiac activation mapping 
Cardiac activity is an electro-physiologic phenomenon including time course and wave 
propagation distribution of excitatory process of the myocardium. To understand this 
complicated phenomenon, we need the isolated beating heart model. It began with the basic 
investigation of Oskar Langendorff who developed a method for investigation of the 
isolated heart (Langendorff, 1895). In 1950s, Dick Durrer, cardiologist and Henk van der 
Tweel, physist opened the Amsterdam era of cardiac activation study. They developed 
instruments to reveal the excitation of heart with ECG. They reported the monumental 
ventricular wall excitation in 2D and 3D results from dog heart [2-5]. After success of dog 
heart model, in 1970, with informed consent of family members, human isolated hearts were 
obtained from individuals who had died, within 30 minutes after death. Thru the isolated 
Langendorff human heart perfusion apparatus, the hearts were perfused with an 
oxygenated, heparinized, modified Tyrode solution, with washed bovine erythrocytes, and 
resumed beating spontaneous sinus rhythm for periods ranging from 4 to 6 hours. During 
the activity, electrical activity of the heart was recorded from epicardial activity by hand-
held electrodes and intramural activity by needle electrodes using 14-channel Ampex tape 
recorder with 870 terminals. They reported the 2D and 3D isochronic representation of atrial 
activation of an isolated normal human heart at first (fig.1) [6]. 
 
 
 
Fig. 1. Isochronic representation of the normal human atrial activation from isolated 
Langendorff human heart perfusion apparatus made by Durrer et al. at first. Reprinted with 
permission from Ref. 6 
www.intechopen.com
 Current Status and Future of Cardiac Mapping in Atrial Fibrillation 
 
95 
First atrial epicardial excitation mapping in atrial arrhythmia (atrial flutter) was performed 
during open heart surgery in a patient with atrial arrhythmia (atrial flutter) and rheumatic 
mitral and aortic valve disease was reported in 1971 by Wellens et al. [7]. They made the 
inferred propagation map from the atrial excitation (Fig.2). 
 
 
Fig. 2. Atrial epicardial excitation recordings and suggested spread in a patient having atrial 
flutter at first. Reprinted with permission from Ref. 7 
Another important breakthrough is the development of pulse generator or stimulator, made 
by engineer Leo Schoo et al. with reproducible high accuracy [8]. It helps to be possible to 
map by placing catheters at different sites in the hearts. 
In the early 1960s, the term “body surface mapping” was coined by Taccardi B et al. Multiple 
unipolar or bipolar leads were recorded from the body surface in dogs [9] and in humans 
[10] to display and analyze the complexity of potential distribution on maps. Next important 
work of body surface mapping is ECGI which have been studied by Rudy Y et al. for several 
decades. 
Endocardial contact mapping under fluoroscopic control is the most widely applied current 
technique for diagnostic electrophysiology study. It involves recordings of electric signals at 
multiple sites of the heart, such as high right atrium, coronary sinus, left atrium via septal 
puncture, right ventricular apex and His bundle area using bi/quadri/multi-polar catheters. 
With the increase in complexity of catheter technology and modern computerized mapping 
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technique, the classical endocardial electrogram recording via a few positioned catheters 
appeared old-fashioned more and more. 
New mapping technologies are under development actively. CARTO, CARTO Merge 
(Biosense-Webster, Baldwin Park, CA, USA), Real-time Position Management (RPM) 
(Cardiac Pathways-Boston Scientific EP Medsystems, Sunnyvale, CA, USA), NavX (St. Jude 
Medical, Inc., St. Paul, MN, USA), Ensite 3000 (St. Jude Medical, Inc., St. Paul, MN, USA) 
hane been introduced recently and used actively worldwide now. We describe these new 
mapping technologies in detail at this chapter. 
3. Body surface potential mapping (BSPM) 
Isopotential body surface maps are used to provide a complete picture of the effects of the 
currents from the heart on the body surface. The potential distributions are represented by 
contour lines of equal potential, and each distribution is displayed instant throughout 
activation or recovery, or both. Since Body surface mapping was introduced, its role has 
been proved in the field of ischemia detection, accessory pathway localization, Brugada 
syndrome, long QT syndrome, and idiopathic VT and reentrant VT analysis, which have 
abnormalities of relatively big enough signal, QRS activity, ventricular activation to be 
detected easily. However, for AF, very weak signal, F wave activity is too small to be used 
as a definite diagnostic solution by BSPM. Body surface potential mapping of atrial events 
was first described by SippensGroenewegen et al. in characterizing P waves during ectopic 
atrial activation [11] and during atrial flutter [12] in 1998. This system uses many leads, 
more than 12 lead-standard ECG. BSPM records simultaneously all signals from all leads, 
not sequential acquisition of endocardial signals from contact-based conventional 
endocardial mapping. Therefore, BSPM results in real-time characterizing and localizing the 
pattern and propagation route of AF. Guillem et al. reports 40+16 leads systems in 16 AF 
patients with 2,048 Hz sampling rate, 1 μV resolution, and 500 Hz bandwidth (fig.3) [13]. 
Using 240-seconds recordings, wavefront propagation maps were classified according to the 
different patterns; I (single wavefront), II (single wavefront with wave breakages and 
splitting) or III (multiple simultaneous wavefronts). This classification showed to be highly 
reproducible over 4 minutes, and these results give us new insights of varing AF 
characteristics, from simple pattern to very chaotic ones. 
Similar AF pattern analysis was also made by Kornings et al. using epicardial contact 
mapping electrode, and this will be described later in the part of “epicardial contact 
mapping” of this chapter. 
In spite of limited usefulness, non-invasive cardiac mapping, such as BSPM, has unique 
necessity for (i) screening people with genetic predisposition or altered myocardial substrate 
for risk of life-threatening arrhythmias, in order to take prophylactic measures; (ii) specific 
diagnosis of the arrhythmia mechanism to determine the most suitable intervention; (iii) 
determination of cardiac location for optimal localized intervention (such as ablation, 
pacing, targeted drug delivery or targeted gene transfer); (iv) evaluation of efficacy and 
guidance of therapy over time; (v) studying the mechanisms and properties of cardiac 
arrhythmias in human, where the electrophysiological substrate is quite different from 
experimental animal models used thus far for this purpose [14]. Although these procedures 
are of interest, their clinical utilities have not been established yet. 
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Fig. 3. Body surface potential mapping (BSPM) is a non-invasive simultaneous mapping. (a) 
Left panel; Arrangement of the electrodes and belt used for their attachment to the patient. 
A total of 56 ECG leads were placed on the chest over the atria on the front (n=40) and on 
the back (n=16). (b) Right panel; Wavefront propagation maps of three dominant activation 
patterns were shown in AF patients; single wavefront (1), single wavefront with wave 
breakages and splitting (2 and 3), and multiple simultaneous wavefronts (4). Fine figures by 
courtesy of Prof. MS Guillem and Reprinted with permission from Ref. 13 
4. Electrocardiographic Imaging (ECGI) 
ECGI combines alleged established technologies, BSPM and CT in a unique fashion to 
generate noninvasive images of cardiac electrical activity. Rudy Y et al. provided ECGI 
applications in normal heart, heart with a conduction disorder, focal activation initiated by 
right or left ventricular pacing, and atrial flutter, successfully using a multi-electrode vest 
records 224 body-surface electrograms [14]. Electrical potentials and isochrones are 
reconstructed on the heart’s surface using geometrical information from computed 
tomography (CT) and a mathematical algorithm. Left panel of Fig.4 shows the ECGI 
application procedures briefly. A 224-electrode vest strapped to the patient’s torso and 
connected to a multichannel mapping system measured body surface potential (a), and then 
the patient underwent a thoracic CT scan (b). The CT images provided epicardial surface 
geometry and vest-electrode positions (c). The potential and geometry data were processed 
through ECGI software (CADIS) (f). Through this process, ECGI isochrones map and 
epicardial surface potential map were constructed (g). Right panel of Fig.4 shows the normal 
atrial isochrone map (a) and atrial flutter isochrones map (b) having the reentrant circuit 
beginning from isthmus, entering septum, emerging from Bachman bundle and propagating 
down RAFW (right atrial free wall) to reenter isthmus again. Wang et al. reported the 
successful ECGI isochrones map in scar-related atypical atrial flutter with a high spatial and 
temporal resolution [15]. 
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Fig. 4. ECGI application procedure (Left panel) and atrial activation ECGI map (Right panel) 
in nomal conduction (a) and atrial flutter (b). In Left panel, a 224-electrode vest strapped to 
the patient’s torso and connected to a multichannel mapping system measured body surface 
potential (a), and then the patient underwent a thoracic CT scan (b). The CT images 
provided epicardial surface geometry and vest-electrode positions (c). The potential and 
geometry data were processed through ECGI software (CADIS) (f). Through this process, 
ECGI isochrones map and epicardial surface potential map were constructed (g). In Right 
panel, the normal atrial isochrone map (a) and atrial flutter isochrones map (b) having the 
reentrant circuit beginning from isthmus, entering septum, emerging from Bachman bundle 
and propagating down RAFW (right atrial free wall) to reenter isthmus again. ECGI is a 
non-invasive simultaneous BSPM mapping, not sequential invasive endocardial contact 
mapping. Reprinted with permission from Ref. 14 
ECGI has higher results in resolution than BSPM, which located pacing sites to within 7mm 
in RV and 11mm in LV. It results in clinical benefit to explore source origin during 
troublesome catheter work. 
Recently, Patient-specific volume conductor modeling with magnetic resonance imaging was 
reported by Pfeiter et al. in 2008 [16]. They used 1.5 Tesla cine MRI images, and makes volume 
conductor model using (i) segmentation, (ii) extraction process of chest, lung, and blood mass, 
(iii) myocardial reconstruction, and (iv) volume conductor integration. And using 62 channel 
Mark-8 system (Biosemi V.O.F.), body surface potential map is acquired and defines by 
Wilson-Central-terminal (WCT) with 2048 Hz sampling rate, and band-filtered with a lower 
and upper edge frequency of 0.3 and 400 Hz, respectively, so the AC resolution of them was 
500nVit-1 (16 bits per channel) (Fig.5). This method gives a fast and accurate insight to us non-
invasively. Still, it is remained not at clinic but at experimental circumstances. 
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Fig. 5. Patient-specific volume conductor model using 62 channel body surface potential and 
MR image integration shows activation time estimation having accessory pathway in WPW 
syndrome patient. This is first personalized simultaneous BSPM with MR mapping. 
Reprinted with permission from Ref. 16   
5. Electrophysiologic endocardial contact mapping 
Catheter or surgical ablation has evolved to be the treatment of choice in patients with a 
broad spectrum of cardiac tachy-arrhythmias including atrial fibrillation. The most 
important requirement for successful ablation is the exact mapping of arrhythmia, focal or 
reentrant, and identification of target sites during the electro-physiologic study. 
Conventional classic mapping needs on fluoroscopy, marked x-ray hazard during 
procedure, and leads to low spatial resolution and inaccurate navigation to a target. 
Classical endocardial contact mapping techniques basically depend on electrical information 
from endocardial contact electrodes and on anatomic information from fluoroscopic 
endocardial contour images. Activation sequence mapping, pace mapping and entrainment 
mapping are the classical methods of contact catheter mapping. Activation sequence 
mapping uses the timing of electrograms from roving catheter during arrhythmia with a 
timing of a reference signal to identify early signal or propagation of activation. It is useful 
to detect focal arrhythmias, such as focal atrial tachycardia or RVOT tachycardia. Pace 
mapping is helpful for source identification of reproducible arrhythmia by pacing at source 
origin with similar cycle length. Entrainment mapping is used to confirm macro-reentrant 
circuit having an excitable gap. These classical mapping methods are moderate x-ray 
hazard, time-consuming, technically difficult, not completely reproducible, and most of all, 
not suitable for hemodynamically unstable patients or transient arrhythmias with short 
duration. To overcome these weak points, several technical advances have been made since 
1997 [17]. 
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5.1 CARTO mapping 
CARTO (Biosense Webster, Diamond Bar, CA, USA) is a non-fluoroscopic electro-
anatomical real-time high-resolution most-widely used 3D mapping system composing with 
magnetic field sensor tip catheter on the magnetic field emitter pad, which was introduced 
in 1996 at first [18]. Nowadays, CARTO-guided left atrial circumferential ablation (48% of all 
AF treatment patients) is the most commonly used techniques in AF treatment and drug-off 
success rate is 70%, overall success rate 80% according to the recent worldwide survey [1]. 
The sensing of magnetic field by location sensor enables the exact location of the tip with 
high accuracy, 1mm. Fig.6 shows the basic mechanism of CARTO to localize the tip location 
[19]. A tiny location sensor is embedded in the catheter tip consisting of three miniaturized 
coils that is tracked by the CARTO system. The locator pad placed beneath the patient table 
generates 3 ultra-low magnetic fields to identify the location and orientation of the sensor. 
The mapping catheter and reference patch are plugged into the junction box and signals are 
sent over to the electrophysiology recording systems. ECG signals and location information 
are sent to a data acquisition and display system that analyzes the signals, determines 
location of catheter tip, and generates maps using the previously collected anatomical and 
electro-physiologic data. The accuracy of CARTO was tested in vitro and in vivo studies and 
reported highly reproducible and accurate with 1mm error range [20]. 
 
 
Fig. 6. Basic mechanism and typical setup of the CARTO electro-anatomical mapping system 
(a) A tiny location sensor is embedded in the catheter tip consisting of three miniaturized coils 
that is tracked by the CARTO system. The locator pad placed beneath the patient table 
generates 3 ultra-low magnetic fields to identify the location and orientation of the sensor. (b) 
Typical setup of the CARTO electro-anatomical mapping system in the electro-physiology 
laboratory. Fine figures by courtesy of and Reproduced with permission of the Anatolian 
Journal for Cardiology/AVES Publishing, from Copyright 2002, Firat Duru. Ref. 16 
CARTO is a very useful tool in mapping for sustained atrial tachycardias, macroreentrant 
atrial arrhythmias after surgical correction of congenital heart disease, and ventricular 
tachycardia of post myocardial infarction or other structural heart disease, and useful in 
isthmus dependent atrial flutter and idiopathic ventricular tachycardia. Basically the 
CARTO system makes map by contact-based sequential acquisition of endocardial signals, 
for construction of 3D electro-anatomical maps, it takes 30 minutes or more, very time 
consuming. Therefore, if the arrhythmia is not sustained or has varying cycle lengths, or in 
the patient who is hemodynamically not well tolerated, or unstable catheter location during 
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intra-cardiac activation and patient movement, CARTO sequential mapping is not possible 
or inaccurate, requiring the reconstruction of a whole new map. CARTO XP improves some 
these drawbacks. The other limitations of CARTO include that it is mostly applied to single 
target chamber only per one trial, and it is impossible to obtain information from the 
epicardial activity. Risk to patient from invasiveness during procedure, higher costs and 
limited reusability of this system is another hurdle to prevent widely distribution. 
5.2 CARTO Merge mapping 
CARTO Merge (Biosense Webster, Diamond Bar, CA, USA) is a recently developed fusion 
system of 3D CT or MR images with an electro-anatomic map. Fig. 7 shows the differences 
between CARTO and CARTO Merge systems for right atrium [21]. 
 
  
Fig. 7. CARTO (Left) and CARTO Merge (Right) map in right anterior oblique view of right 
atrium from postoperative Fontan operation patient. In CARTO Merge, CT based anatomy 
(blue) and underlying map (mesh) show the detailed anatomy of right atrium with coronary 
sinus, connected pulmonary arteries and its branches from postoperative Fontan patient. 
CARTO and CARTO Merge are sequential endocardial contact mapping. Reprinted with 
permission from Ref. 21 
In CARTO Merge, the high-resolution anatomical information from contrast enhanced 64-
slice cardiac computed tomography (CT) was reconstructed and the heart chambers were 
segmented and implemented in the new electro-anatomical mapping system. 
However, roving magnetic tip catheter mapping is basically a sequential, beat-by-beat 
approach, which demands stable rhythm and fixed reference point, and may have possible 
error from ferromagnetic noise. Multiple factors create discrepancies between electro-anatomic 
maps and merged, preacquired computed tomographic images. The accuracy of the integrated 
3D geometry is highly dependent on image quality and on the merge process. Errors may 
develop from changes in cardiac chamber volume or rhythm occurring between the time of 3D 
anatomic image acquisition and electro-anatomic mapping in EP lab. Gating of image 
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acquisition to the cardiac cycle and respiratory phase may affect rendered volumes. Usually 
volume image acquisitions were gated at 80% of the R-R interval for atrial and at 0% of the R-R 
interval (R wave) for ventricular imaging during the end-expiratory phase. 
5.3 NavX mapping 
Next to CARTO, the NavX (Endocardial Solutions, Inc., St. Paul, MN, USA) is the 2nd 
widely used 3D non-fluoroscopic mapping system using transthoracic low-power electrical 
currents to enable localization of endocardial electrode catheters, which was published in 
1999 [22]. NavX has advantages in multiple endocardial catheter real-time visualization with 
a respiratory compensation algorithm. The other advantage is the effect on radiation 
exposure reduction. NavX is significantly higher than others in x-ray hazard reduction, 
median fluoroscopy time is 13 min conventionally, 6 min with CARTO, 4 min with NavX 
[23]. NavX system measures the local voltage on every standard intra-cardiac electrode and 
calculates the electrode position in 3D space. Additionally, it labels any individual electrode 
of each catheter. The ability to visualize and label electrodes on both the circular mapping 
and the ablation catheters may offer a great benefit in ablation procedures. NavX is built on 
the principles of LocaLisa. It creates 3D images of the catheters, based on a low-current 
electrical field of 350 μA at a frequency of 5.68 kHz, generated by three pairs of nominally 
orthogonal skin patches in X, Y, and Z axes. The measured voltage and impedance sensed 
by these catheter electrodes are proportional to the distance of the electrode from the 
patches, thus allowing calculation of the location of the catheter in 3D space. The potentials 
are defined with respect to a reference electrode, which is a surface electrode or an internal 
fixed electrode such as a coronary sinus catheter electrode that presents the origin of the 
coordinate system. After impedance calibration, the position in space of each electrode can 
be determined for a wide range of patient body masses (34-115 kg) with the accuracy of 0.6 
mm. To control variations related to the cardiac cycle, acquisition is gated to any selected 
electrogram to need. Compensation for respiratory movements is also conducted, the 
respiratory motion artifact is measured and subtracted from the measurement or roving 
electrode position. Using this, 3D geometry reconstruction of heart chambers is performed 
to guide treatment. However, 3D atrial reconstruction using NavX system is not fully 
reliable yet. In spite of all, NavX enables a significant reduction in fluoroscopy time and 
total procedure duration compared with the conventional- fluoroscopy-based approach. By 
using the Penta-array catheter each with 4 electrodes, sequential acquisition of the contact 
electrogram activity obtained as the penta-array catheter is swept up, therefore rapid 
activation mapping can be performed as Fig.8 [24]. 
 
 
Fig. 8. Penta-array catheter (A) having each 4 electrodes and sequential swept up contact 
mapping are displayed (B). NavX system is basically sequential endocardial contact 
mapping. Reprinted with permission from Ref. 24 
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5.4 Real-time Position Management mapping 
Another new mapping system is Real-time Position Management (RPM) (Cardiac Pathways-
Boston Scientific EP Medsystems, Sunnyvale, CA, USA) system that was first described by 
de Groot et al. in 2000 [25]. RPM uses ultrasound to measure the distance between the 
reference ultrasound transducer and catheters. Two reference catheters and one mapping 
catheter were introduced by either arterial or venous approach. Ultrasound ranging 
technique is used to (i) construct a 3D representation of catheters including electrodes and 
transducers, anatomic structures, and ablation sites and (ii) display real-time movement of 
the tip and shaft of the catheters. As a non-fluoroscopic map-guide system, RPM, cooled RF 
ablation was tested in animal experience [26]. RPM system has advantages over CARTO or 
NavX system regarding stable catheter position that is minimally influenced by body, 
cardiac, respiratory movement, and sweating, and also no need for skin electrodes or 
patches. However, one major disadvantage is that the RPM system requires a special 
catheter, a mapping catheter and two reference catheters equipped with ultrasound 
transducers which limited steerability of the mapping catheter, and dislocation of the 
reference catheters due to roving catheter manipulation. 
5.5 Clinical Implication  
We described briefly several mapping systems having current clinical usage. New technical 
advance in mapping system results in new treatment concept and clinical success. Substrate 
CFAE mapping in AF, activation/propagation mapping in atrial tachycardia/atrial flutter, 
and voltage mapping in scar-related atrial tachycardias are the current useful examples of 
3D electro-anatomical mapping systems. From the data acquisition of single mapping 
system, several maps are generated such as activation map, propagation map, voltage map, 
frequency map and geometric map. Activation map describes the dispersion of activation 
times in the mapped region. Propagation map is a dynamic graphic representation of the 
activation wavefront throughout the cardiac cycle. Voltage map is a graphic representation 
of the peak-to-peak voltage of the local electrograms recorded. Frequency map is a graphic 
representation of the frequency spectra, such as dominant frequency (DF) or complex 
fractionated atrial electrogram (CFAE), of the local electrogram recorded. Geometric map 
present graphic representation of the mapped anatomy. 
Substrate mapping is benefit to treat AF by substrate modification. In 1959, Moe and 
Abildskov hypothesized that AF is due to multiple randomly propagating reentry waves in 
the atrium, suggesting that functional reentry is the mechanism underlying fibrillation [27]. 
Wijffels et al. confirmed that AF was shown to require at least 6 to 8 circulating reentrant 
wavefronts [28]. Maintenance of AF depends on a critical atrial mass on conduction velocity 
and refractory periods in the atrial tissue to support functional reentry. Since Cox et al. 
reported the higher success rate in AF treatment using surgical Maze procedure [29-30], 
substrate modification is accepted as a new target for AF treatment and substrate mapping 
is recently accepted as very important one. The Cox-Maze procedure incorporates 4 lesion 
sets and involves; (i) encirclement of the Pulmonary Veins, (ii) a lesion joining the 
circumferential PV lesion to the mitral annulus with amputation of the left atrial 
appendages, (iii) a circumferential lesion in the Coronary Sinus, and (iv) ablation of the right 
atrium. However, Maze procedure remains complex and is associated with a significant 
increase in cardiopulmonary bypass time, morbidity, and mortality. 
Although the exact mechanisms of AF treatment by linear lesion set like surgical Maze 
procedure still remains not completely elucidated yet, (i) reduction of excitable LA 
myocardial mass may be account for these success. Besides mass reduction, (ii) attenuation 
of vagal innervations, (iii) abolition of non-PV foci, especially related with ligament of 
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Marshall, and (iv) elimination of anchor circuits confined to LA-PV region are the reason of 
importance of substrate mapping [31]. 
Two different parameters were used to display the substrate mapping, one is voltage and 
the other is frequency. In frequency, complex fractionated atrial electrogram (CFAE) is the 
parameter indicated for the fractionation of atrial activity, and dominant frequency (DF) is 
the largest peak frequency of the atrial activity spectrum. Fig.9 shows the comparison of the 
CFAE map and DF map in same AF patients. [32]. 
 
 
Fig. 9. Comparison of the regional distribution of the DF map (upper) and CFAE map 
(lower) using NavX sequential mapping system in same AF patients. The intracardiac 
bipolar electrogram and corresponding frequency spectra during AF are shown in right 
panels. The most fractionated areas (shortest FI, site E) in the LA low posterior wall are in 
the periphery of the high-frequency sites of AF (highest DF site, site C) near the lateral 
mitral isthmus. CFAE ablation did not terminate AF; however, linear ablation in the lateral 
mitral annulus crossing the highest DF site successfully terminated AF. Reprinted with 
permission from Ref. 32 
Nademanee et al. reported that CFAE map-guided left atrial (LA) ablation terminated 
sustained AF in 95% of patients, resulting in excellent clinical outcomes (1 year AF-free rate, 
91%) and improved mortality rates [33]. However, the electro-physiologic mechanism of 
CFAE has not been clearly elucidated yet. CFAE regions are predominantly located at the 
septum, roof, and LA appendage (LAA) with low voltage surrounded by a high voltage area 
and low conduction velocity in patients with AF. CFAE cycle length was longer, and % area 
of CFAE was smaller in patients with an enlarged LA or low-voltage LA [34]. High plasma 
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concentrations of TGF-beta and TIMP-1 had lower LA voltage and greater LA volume 
significantly in non-valvular AF patients [35]. 
RF ablation of atrial flutter, focal atrial tachycardia, AV nodal reentry tachycardia, and scar-
related (incisional) atrial reentrant tachycardia under activation/propagation mapping 
using CARTO or NavX are accepted as clinical success. Especially, incisional atrial 
tachycardias in patients following surgery for congenital heart disease having complex 
structural abnormalities were treated by catheter ablation [36]. Electroanatomical activation 
3D map allowed a rapid distinction between focal and reentrant mechanisms and 
visualization of the activation wavefronts along anatomical and surgically created barriers, 
such as reentrant tachycardia propagating through the tricuspid annulus-vena cava inferior 
isthmus or along peri-atriotomy loops. Target sites in complex congenital heart disease 
patients are often slow-conducting narrow isthmus bordered by areas of scar tissue [37] and 
voltage criteria have been developed by areas of scar tissue by De Groot et al. [38]. Voltage-
based scar-related delineation in patients with congenital heart disease is the good example 
of 3D electroanatomic mapping which has clinical impact. 
In spite of many clinical advantages, endocardial contact mapping has several weak points 
to be solved, (i) detection source problem, alteration or interference of magnetic field or 
ultrasound, (ii) contact issues, missing or noise signals from contact problems, (iii) motion 
artifact from reference point, cardiac cycle, respiration movement, (iv) un-mappable 
arrhythmia, (v) sequential fragmented map, not simultaneous single snapshot map, (vi) 
fractionated electrograms not to trace whole propagation of each F wave, and (vii) position 
error during image registration. However, in spite of several weak points, these endocardial 
contact maps provide us valuable insights into the mechanism of arrhythmias and enhanced 
understanding of substrate –EP relationships. 
6. Non-contact endocardial mapping 
The most important drawback of contact mapping is the error from the missing or noisy 
signal due to poor contact problem. So, some electrograms were deleted when artifacts or 
poor contact were observed. To overcome this problem, noncontact concept was introduced 
in 1987 by Taccardi B et al. in which intra-cavitary potentials were measured from olive-
shape probe electrodes introduced through the LV apex of animal heart [39]. 64 Multi-
electrode array (MEA) (EnSite Array, St. Jude Medical, St. Paul, MN, USA) is very rapid, 
3360 virtual electrogram complete map generation on a single beat, relatively accurate, and 
usable even in hemodynamically unstable or non-sustained VT patients. However, this 
system has limitations in (i) distance problem, between catheter and tissue, decreased 
accuracy more than 34mm apart from tissue, (ii) signal-to-noise ratio problem, (iii) chamber 
size dependent, and (iv) virtual electrogram not real one, (v) inadequate substrate mapping 
and (vi) the associated moderate costs. 
Recently, an ultrasound-based 3D imaging modality, CARTO-based 3D ultrasound image 
system (Biosense Webster Inc., USA) has been developed to minimize merge process error 
[34]. The axial CT images were transferred to the electro-anatomic mapping system 
equipped with CARTO Merge image integration software (Biosense Webster). The surface 
reconstruction of the RA with superior vena cava, left arium, pulmonary veins, right 
ventricle, and left ventricle were segmented from each chamber volume. An electro-
anatomic location sensor was incorporated into the IntraCardiac Echocardiography (ICE) 
catheter tip to allow the establishment of (i) tip location in 3D space, (ii) tip direction, and 
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(iii) the origin and direction of the 2D ICE sector image. Three second segments of 2D 
ultrasound images were acquired during ECG gating to a coronary sinus atrial electrogram 
for atrial imaging, and ECG gating to the R wave of V1-3 electrogram for ventricular 
imaging. This system was not automatically gated to respiration, so the images were 
acquired in late expiration phase (79%). Point-to-point component interpolation from a 
family of the chamber contour data makes the complete volume rendering and 3D 
geometry. They reported the point-source error of 3D ultrasound-derived geometries was 
2.1mm for atrial and 2.4mm for ventricular sites, and significantly less than CARTO Merge 
CT images, 3.3mm for atria and 4.8mm for ventricle. Fig.10 shows 3D ultrasound geometry 
creation [40]. 
 
 
Fig. 10. CARTO-based 3D ultrasound geometry creation. A) 2D ICE view of the LA with 
endocardial perimeter (left) and simultaneously rendered endocardial contour (right). B) 
Collated multiple LA perimeters created with multiple catheter rotations. C) Overall 
segmented volume using point-to-point component interpolation. D) Complete LA and PV 
geometry created from individual volume components. LA indicates left atrium; LAA, left 
atrial appendage; PV, pulmonary vein; RS, right superior; RI, right inferior; LS, left superior; 
and LI, left inferior.  It took some time to make several contours for each chamber. This is an 
invasive non-contact endocardial sequential mapping. Reprinted with permission from Ref. 40 
In canine experimental model, a 3D ultrasound-derived geometry was created by 51 
contours for RA, 22 contours for SVC, 22 contours for LA, 7 contours for PV and 8 contours 
for LAA. So, the total rendering time was 23 minutes for RA and 26 minutes for LA. The 
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limitations of this 3D US derived images are (i) error from respiratory cycle, (ii) poorer 
resolution than CT imaging, (iii) error from acoustic shadowing or incomplete penetration 
of ultrasound, (iv) not fully contact images. 
7. Epicardial contact mapping 
Unlike the invasive endocardial sequential mappings such as CARTO, NavX, MEA, etc, 
Body surface potential mapping (BSPM) or ECGI gives us non-invasive simultaneous 
electrical information, but their resolution is limited due to relatively weak signal intensities 
from F-wave of AF. Epicardial contact mapping helps to show exact propagation route of F-
wave. 256-channel 3-dimensional dynamic mapping system with intra-operative epicardial 
patch electrodes was used [42]. Successful results were reported, but it is useful only during 
the operation, so it is still invasive, useless for preoperative exam or follow-up, and it does 
not show normal activity under physiological conditions, such as closed chest, no 
anesthesia, presence of neural inputs, mechanical loading, and normal perfusion in intact 
human subjects. Epicardial electrode system has also limitation to detect any conduction via 
 
 
 
Fig. 11. Using 244-lead epicardial electrode mapping systems (upper), three different AF 
types were classified along mapping results (lower) in RA free wall of AF patients, such as 
single uniformly propagating waves (I), single non-uniformly conducting waves or two 
wavelets (II) and three or more wavelets associated with multiple areas of slow conduction 
and arcs of conduction block (III). This invasive epicardial contact mapping is simultaneous 
mapping to show the different pattern of AF complexity. Reprinted with permission from 
Ref. 42 
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inter-atrial septum and coronary sinus musculature. However, epicardial contact 
mapping gives us some clue of AF characteristics to understand their pathophysiology of 
different propagation pattern like previously described report by Guillem et al. [13]. 
Konings et al. reported three different types of AF according to the F-wave propagation 
pattern using 244-lead epicardial mapping electrode system in RA free wall (Fig.11). They 
classified AF as the degree of complexity of atrial activation during fibrillation, (i) single 
broad wave fronts propagating without significant conduction delay, exhibiting only 
short arcs of conduction block or small areas of slow conduction not disturbing the main 
course of propagation, (ii) single waves associated with a considerable amount of 
conduction block and/or slow conduction or the presence of two wavelets, and (iii) three 
or more wavelets associated with areas of slow conduction (<10 cm/s) and multiple arcs 
of conduction block [42]. 
Patients with a left atrial (LA) thrombus are accepted as a known contraindication for 
endocardial mapping and procedure. In this circumstance, hybrid epicardial and 
endocardial mapping and ablation technique would be possible [43]. Mapping catheter is 
inserted into pericardial space via a subxyphoid approach. Although this new approach 
resulted in a successful outcome for LA thrombi patient, the risk of complications such as 
hemo-pericardium, phrenic nerve injury, great vessel injury, coronary artery damage or 
pericarditis should also be considered before procedure. 
8. Magnetocardiographic action potential activity mapping 
Magnetocardiographic action potential activity mapping is a new experimental non-
invasive non-contact high-sensitive simultaneous 3D mapping system for AF using 
superconducting quantum interface device and CT image co-registration. It is very rapid to 
register signals like an ECG, but very sensitive enough to analyze F-wave for source 
localization sufficiently, having many channels, more than 64 channels simultaneously, and 
shows results easily to physician as a 3D map. Its feasibility were reported in 2007 at first 
[44], and we introduce it for understanding including basic concept, history, main 
differences between ECG and MCG, its resolution, source localization, CT co-registration, 
clinical application, MCG studies at rhythm disorders, etc. in this chapter. 
8.1 Biomagnetism 
The movement of charged ions such as Na, K, and Ca across cell membranes generates 
electrical potentials on body surface which can be detected by electrographic mapping 
methods such as ECG. The same ion fluxes also generate electrical currents, which in turn 
give rise to magnetic fields. These magnetic fields can be registered outside the body, and 
measurement of the biomagnetic fields generated by the electrical activity of the human 
body is termed biomagnetism. The magnetic field strength is quantified with field density, 
whose unit is the Tesla (T). The magnetic fields of the body are so weak, for example, the 
magnetic field of the heart is < 100 picotesla (1 pT = 10-12 T) and that of the brain is 
femtotesla (1 fT = 10-15 T) (the earth’s magnetic field is 10-4 T), so therefore some kind of 
shielding from external magnetic fields and high sensitive device are usually necessary. 
Biomagnetic measurements have been performed on several organs, besides the heart with 
electrical activity including the brain (magneto-encephalogram, MEG), eye (magneto-
oculogram, MOG) and peripheral nerves (magneto-neurogram, MNG). MEG is currently 
used world-wide and studied actively to localize brain lesion such as epileptic focus, and 
gives higher information than EEG. 
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8.2 History of MCG 
Magnetocardiography(MCG) is a technique to register the extracorporeal magnetic field of 
the heart which is generated by the same currents as the ECG. First MCG signals were 
registered in 1963 using a set of two copper coils and no external shielding by Baule et al. 
[45]. In 1967, MCG measurement was performed in a magnetically shielded room to cancel 
out the effects of external magnetic fields such as the earth’s magnetic field and that of 
urban traffic [46]. A significant step forward was the invention and implementation of the 
superconducting quantum interference device (SQUID) in liquid helium at 4.2 °K (-269 °C) 
at 1970 by Cohen et al. [47]. During the next two decades, MCGs were registered with single 
channel device, and mappings were performed by placing the sensor at several locations 
over the thorax and measuring signals from one location at a time. First normal MCG 
patterns based on such mapping systems was reported in 1978 by Saarinen et al. [48]. In the 
1990’s, multi-channel devices have emerged, allowing simultaneous recording of the 
magnetic signals over large precordial areas by Van Leeuwen et al. [49-50]. Today, MCG 
measurements can be performed with highly sensitive second-order SQUID gradiometers 
sensors in low-cost aluminium magnetically shielded rooms, resulting in high sensitivities, 
and with a modern multi-channel device, MCG registration can be performed in a few 
minutes, rendering the method suitable for clinical patient measurements. 
8.3 Main differences between MCG and ECG 
MCG has morphological features similar to the P-wave, QRS complex, and T- and U- waves 
of the ECG and the temporal relationships between them are generally the same [48]. The 
main difference between spatial ECG and MCG patterns is the spatial angle of 90° between 
them, an essential feature of the MCG and ECG maps [51]. ECG and MCG are sensitive to 
different configurations of the source current: body surface potential measurements reflect 
the flux of the primary current distribution whereas the magnetic measurements are 
associated with the curl of the same source [52]. Therefore, certain source configurations can 
be undetectable in one measurement but visible in the other. A radial dipole in a sphere 
produces no magnetic signal outside the volume conductor, on the other hand, a vortex type 
current, curl current, a loop current would be undetectable in ECG measurements, but 
generates a measurable magnetic field. Almost all MCG studies are based on measurement 
of the magnetic field component perpendicular (radial or Z-component) to the anterior chest 
(Bz). MCG is thus most sensitive to currents tangential to the chest surface, whereas 
especially chest leads of ECG are more sensitive to radial currents. MCG is more sensitive to 
the terminal phase of the depolarization when the activation wavefront occurs in a more 
tangential direction than at the initial part [53]. ECG (the isointegral BSPM maps) shows 
abnormalities mainly during the depolarization period, whereas in MCG, better 
discrimination results from use of the abnormalities in the repolarization period [54]. MCG 
is also not affected by conductivity variations caused by the lungs, pericardial effusion, 
muscles, and skin, unlike ECG [51]. In MCG, there are no potentials generated by the skin-
electrode interference needing to be filtered out, it does not require skin-electrode contact, 
which is prone to noise, as in body surface ECG. MCG is totally non-invasive and even non-
contact device. 
8.4 Temporal and spatial resolution of MCG 
Bioelectric and biomagnetic studies offer functional information about electrically active 
organs, such as the heart and the brain, which is difficult to obtain by other imaging 
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techniques. For example, MRI, computed tomography (CT) and X-ray imaging mainly 
provide only static anatomical information with relatively good spatial resolution. The 
alternative functional imaging methods, such as perfusion-MRI, PET, and SPECT, involve 
the use of intravenous enhancing markers to produce knowledge about metabolic process. 
In addition, the time resolution of perfusion-MRI, PET and SPECT is only around one 
second and the spatial resolution is only around a few centimeters. As with ECG signals, 
the MCG signals of the heart are obtained relatively good within millisecond time 
resolution. 
In spite of higher temporal resolution of MCG, spatial resolution of MCG has a few 
measurable error ranges. In a phantom study by Fenici et al in 1998 [55], the accuracies of 
MCG dipole localizations were investigated by using a non-magnetic stimulation catheter, 
and the average MCG localization accuracy was 2-7 mm, while Body Surface Potential 
Mapping was 4-10 mm [56]. MCG localization accuracy is dependent to the signal-to-noise 
ratio (SNR) of MCG. With the SNR between 5 and 10, the average localization error was 
found to be 9 ± 8 mm, while for the SNR between 30 and 40, and for the goodness of fit 
between 99.5 % and 100 %, the average error reduced to 3.2 ± 0.3 mm. Therefore, the high 
SNR is essential to have a good spatial resolution. These previous resolution were originated 
from the QRS study. In atrial F wave localization, the F wave localization error is larger than 
QRS wave, because of its small size and irregularly irregular pattern. To minimize the atrial 
F wave localization error, co-registration with MDCT and MCG signals is essential. 
8.5 Source localization 
In source localization studies, the forward problem has to be solved first, i.e. one has to 
calculate the electrical potential or the magnetic field, generated by the current sources in 
the heart, on and outside of the body, respectively. In the inverse problem, the current source 
is determined from the MCG and BSPM measurements. However, even with a complete 
knowledge of the electromagnetic field outside of the source region, the inverse problem 
cannot be uniquely solved because the same field distribution can be produced by infinitely 
many current source configurations. Therefore, restrictive assumptions about the current 
sources are needed. The conventional way is to use equivalent source models for describing 
the actual currents. The parameters of the source model can then be determined from the 
measured data, e.g., in a least-squares sense. In addition to the current source, the media 
surrounding it needs to be modeled. The volume conductor models used in cardio-magnetic 
source imaging studies are usually referred to as torso models. For atrial F wave source 
localization, separative Surface Potential Activation Beamformer (sSPAB) is introduced by 
Kim et al. [44]. 
Minimum variance beamformer (MVB) is a well-known spatial filtering technique 
explaining the covariance matrix of measured fields and the technique is proper to deal with 
rhythmic oscillation fields like F-waves in atrial arrhythmia because the covariance matrix of 
the measured signal contains spatiotemporal information. However, the MVB has two 
intrinsic drawbacks: First, the result is not robust to the source dipole orientation although 
the technique has originally been developed for Equivalent current dipole (ECD) source 
model – a collective excitation of pyramidal cells on the brain cortex can be well 
approximated by the ECD source. Because the dipole orientation estimation prior to 
calculating the source power at the position is crucial to obtain a good result with MVB, the 
estimation should be done very carefully. Moreover, in a heart as opposed to a brain, the 
ECD is not a good model describing heart current sources. Second, MVB is unable to 
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separate one source from the others for correlated multi-sources, especially for successively 
activating sources just like the myocardial current sources. Separative Surface Potential 
Activation Beamformer (sSPAB) is an effective dynamic source localization technique for 
electrical reentrant excitation of myocardium from AF. sSPAB technique is based on 
Minimum varience beamformer (MVB), but it circumvent the drawbacks of MVB mentioned 
previously by adopting Equivalent double layer (EDL) model rather than Equivalent current 
dipole (ECD) and by using higher order statistics of measured signals. 
Current dipole sources are not suitable for explaining the reentrant excitation feature 
appearing on the myocardium. Instead of Equivalent current dipole (ECD), this surface 
source model based on the Equivalent double layer (EDL) model is utilizing the fact that all 
the primary current sources in a heart can be described by epicardial transmembrane action 
potential on the closed surface enclosing the heart. With the Boundary element model (BEM) 
– conductor model considering the effect of the volume current, it confines the dependent 
variables to the action potentials on the Boundary element model (BEM) heart surface. The 
estimated sSPAB power is corresponding to each other the source activity on the heart 
tissue. Therefore, it is no need to estimate the orientation of current dipole at the vertexes. 
The lead fields are calculated by a multi-surface Boundary element model (BEM) consists of 
heart, lung and torso. The source potentials are located only on the heart surface using 
sSPAB technique [44]. 
By using the Independent component analysis (ICA), the F-wave was separated from the 
other activations such as ventricular excitation, and also the feature in a time sequence. 
Generally, Minimum varience beamformer (MVB) uses a covariance matrix of measured 
signals obtained by multi-channel detectors, which means that Minimum varience 
beamformer (MVB) separate sources with the second order statistics (e.g. according to the 
magnitude of variance). The second order statistics are not enough to separate an MCG 
signal into the characteristic components such as P-wave, QRS complex, and T-wave. 
Therefore, higher order statistics of the measured signals are required. Separative Surface 
Potential Activation Beamformer (sSPAB) adopts the JADE algorithm using the 4th order 
cumulants of the measured data. The moving dipole forms a magnetic field trace at each 
sensor position as it moves along a route. The measured magnetic field can be separated into 
several independent waveforms by Independent component analysis (ICA) with a degree of 
freedom in permutation. 
Fig.12 shows some examples of Activity map of action potential (AMAP) as application 
results of separative Surface Potential Activation Beamformer (sSPAB) for clinical use of 
source localization. Fig. 12 (a) and (b) are AMAPs for patients having dimished F-wave and 
coarse F-wave respectively. Patient 1 is a 61 years-old male diabetes with rheumatic valvular 
heart disease. He suffered from severe mitral stenosis (mitral valve area is 0.68 cm2) and he 
has calcified Aortic valve leaflet with leaflet fusion of Rt coronary cusp and noncoronary 
cusp. He has large LA (size 67 mm) and long-standing persistent AF. High amplitude 
activity of action potential can be observed around the inferior part of right atrial surface. 
Patient 2 is a 57 years-old male with rheumatic valvular heart disease showing severe mitral 
regurgitation. It is due to A1 and A3 prolapse of mitral valve leaflet. His LA size is 67 mm 
big and his rhythm is long-standing persistent AF. He shows coarse F-wave in MCG, the 
excitation is very strong and expanded to the ventricle so that we could guess it transferring 
an atrial flutter. 
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Fig. 12. Activity map of the action potential (AMAP) examples produced by sSPAB method. 
Red color implies high activity amplitude on the atrial myocardial surface. (a) Patient I: 
diminished F-wave and high activity on the inferior of Right atrium. (b) Patient II: coarse F-
wave and activity on the RAA expanded to ventricle. 
8.6 Clinical application of MCG 
MCG has been used for many cardiac disorders. MCG can detect exercise-induced myocardial 
ischemia in heterogeneous CAD patient population with several ST-segment and T-wave 
parameters as well as ST amplitude, and spatial evaluation of ischemia-induced post-exercise 
T-wave changes may be useful in localization of the ischemic myocardial region [57]. MCG can 
detect patients with LV hypertrophy [58] and quantify its degree in patients with increased LV 
mass [59]. In patients with acute chest pain and without ST-segment elevation (Non-STEMI), 
MCG predicted CAD with a 97.8% probability and excluded CAD with an 84.8% probability, 
superior to ECG, Troponin I and Echocardiography [60]. 
Fetal MCG recordings are another important application of magnetic measurements to 
detect the heart rate of the fetus and even some cardiac abnormalities throughout the course 
of pregnancy [61], because the ECG signal of a fetus decreases after the 25th week of 
gestation and becomes practically undetectable due to vernix caseosa, an insulating layer 
covering the fetus, while the MCG signal increases [62]. After the 30th week, the ECG signal 
increases again together with the MCG signal [63]. 
8.7 MCG studies at rhythm disorders 
MCG has proven accurate in localization of accessory pathways causing pre-excitation in 
Wolff-Parkinson-White syndrome [64], as well as in localization of the tachycardia points of 
origin [65] and premature ventricular ectopic complexes [66]. MCG have been superior to 
signal-averaged ECG in indicating a propensity toward life-threatening arrhythmias and 
magnetocardiographic intra-QRS fragmentation [67] and QT dispersion have identified 
post-MI patients prone to ventricular arrhythmias [68], the former being independent of the 
extent of LV dysfunction. All of this study targets for rhythm disorders are the relatively big 
signal component, QRS complex. Atrial F wave is very weak and small, so hard to detect 
and analyze, that is the reason why it prevents the study of atrial rhythm disorders using 
MCG. To overcome this hurdle of sensitivity, top-notched DROS SQUID 64 channel MCG 
system and software is used to detect atrial F wave easily. 
8.8 MCG recording and data processing 
MCG signals were recorded at supine position with about 5 minutes (30 to 60 seconds a 
session, several sessions) recording time under the MCG dewar. The MCG system utilizes 
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double relaxation oscillation Superconducting Quantum Interference Device sensors [69-70]. 
The average noise spectral density of the whole system in a magnetic shielded room is 10 
fT/√Hz @ 1 Hz and 5 fT/√Hz @ 100 Hz. The KRISS MCG has 64 planar first-order SQUID 
gradiometers, which measure the tangential components of the cardiomagnetic fields. 
Measuring tangential field components is effective to obtain the overall heart information 
with a relatively small area of sensor distributions, that is, feasible to detect deeply-located 
sources like an electrical activity caused by the atrial excitation [71]. In this system, the tri-
polar magnetic field map patterns were changed into ordinary dipolar field maps by using 
the minimum norm estimate [72]. The typical recording time is 30 to 60 seconds and the 
subjects are in their supine position under the MCG dewar. In Root mean square (RMS) 
peak ratio, supine position gives lesser P than T in ratio, however the real size of amplitude 
of P wave is 1.5 fold larger in supine. Therefore, the signal of P wave is well detected in 
supine position from MCG (Fig.13). [71]. 
 
 
Fig. 13. Comparison of supine versus prone position for adequate MCG signal register. 
Modified reprinted with permission from Ref. 71 
The MCG data of all subjects were analyzed by the application software KRISSMCG64 
(Biomagnetism Research Center, Korea Research Institute of Standards and Science, 
Daejeon, KOREA). The signal processing software provides automatic digital filtering, 
synthetic gradiometer formation, and baseline correction for the acquired records. To 
analyze atrial F-wave in atrial surface, F-wave were separated from other components such 
as P, QRS, and T-wave component in a time sequence using Minimum variance beamformer 
(MVB) localization combined Independent component analysis (ICA), which separate 
successfully waveforms of moving current dipoles. 
8.9 Generation of CT geometry for 3D heart modeling 
In order to make an exact conductor model and to combine anatomical information with 
MCG results, Computed tomogram (CT) images were recorded previously for the 
individual patients. The generation procedure of geometric heart modeling is as follows: (i) 
Heart image preparation from computed tomography having several landmarks for co-
registration with MCG, (ii) Characteristic line data extraction of the heart shape from CT 
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images, (iii) Surface constructions from the extracted line data. This modeling is achieved by 
computer aided Non-Uniform Rational B-Spline (NURBS) procedure. It uses the absolute 
coordinate data as the reading coordinates, creates ASCII file, interpolate NURBS curve 
creation, generates curve by modification and optimization, and finally gives NURBS 
surface creation for modeling. 
By the co-registration process between MCG and CT, the volumetric conductor models were 
established. The conductor model explains the volume current effect in calculation of forward 
problems with the Boundary element model, which results in a more accurate localization than 
in case of using a simple conductor model such as a horizontally layered model. 
8.10 Propagation path tracing (Inferred route) from AMAPs 
From the Activity map of action potential (AMAP) using separative Surface Potential 
Activation Beamformer (sSPAB) and Independent component analysis (ICA), the 
propagation route of the atrial activity were inferred as a MCG map. Fig. 14 shows the 
process for inferring an atrial excitation route originating the F-wave. The AMAP examples 
by using sSPAB for AF demonstrated in other patient, 70 years-old male who had severe 
mitral stenosis (MVA 0.67 cm2) due to severe calcified MV leaflet, large LA (size 60 mm) and 
chronic AF. The measurement and analysis were shown in Fig. 14. As expected, the F-wave  
 
 
Fig. 14. The process for inferring propagation route as a MCG map. (a) Atrial fibrillation 
time traces recorded by using an MCG. The R-and T-waves were chopped for their 
relatively large amplitudes. (b) The separated independent components of the f-waves. The 
time window is corresponding to the red box in the Fig (a). (c) The activity maps of the 
action potential found by using sSPAB; the upper row is corresponding to the #14 
waveform (early excitation) in Fig. (b), and the bottom row is corresponding to the #6 
waveform (later excitation), respectively. The red color implies the active change in the 
action potential for each corresponding waveform. (d) The inferred propagation trace of the 
atrial excitation. LAA, left atrial appendage; RAA, right atrial appendage; LPV, left 
pulmonary vein; RPV, Right pulmonary vein. Reprinted with permission from Ref. 44 
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caused by AF is relatively small compared to R- and T-peaks. The oscillatory behavior of F-
wave between the previous T-wave and the next R-waves can be observed in the multi-
channel MCG record (fig. 14(a)). Using the ICA process in the sSPAB, we can separate the 
independent components of the F-waves and each the waveform can be marked visually 
time by time (fig. 14(b)). In Fig. 14(c), the Activity maps of the action potential were found 
by using sSPAB; the upper row is corresponding to the #14 waveform (early excitation) in 
Fig. 14(b), and the bottom row is corresponding to the #6 waveform (later excitation), 
respectively. The left panels are seen from the right lateral side of the subject and the right 
panels are seen from the right posterior position of the subject. The red color on the 
myocardium implies the active change in the action potential for each corresponding 
waveform. From the AMAPs at the two sequential time instants, we can infer the 
propagation trace of the atrial excitation. The expected propagation route was drawn in Fig. 
14(d) [44]. 
8.11 Reproducibility test of MCG AMAP source localization 
To confirm whether AF source localization by my methods is reproducible or not, MCG data 
sets of twelve AF patients were analyzed. From each MCG data set, seven records were 
collected randomly with same time interval, like as around 1 sec, 10 sec, 20 sec, 30 sec, 40 
sec, 50 sec and 60 sec records from the 60 seconds MCG data, and around 1 sec, 5 sec, 10 sec, 
 
 
Case 1
0.5 seconds, 0.5 V  
Fig. 15. Reproducibility test result of AF source localization using MCG, ICA, and sSPAB 
methods. Seven F wave records from different time period with 5 seconds interval shows 
very irregular F wave, however, their source localization results is similar each other in 
activity and location. Due to the irregularity of F wave characteristics, they are not 
completely identical in the time, activity intensity and dispersion. 
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15 sec, 20 sec, 25 sec, 30 sec records from the 30 seconds MCG data. Each record is 0.5 
second-long and moved a little to acquire only F wave without QRS and T wave. Each 
record is used to make 3D AF source localization through baseline correction filtering 
without averaging, raw data analysis and 3D Equivalent double layer (EDL) localization 
method in sSPAB algorithm of KRISSMCG64 application software. The relative locations of 
AF source are similar between them, but some different in activity strength and in detailed 
location each other so, not completely identical in all (Fig. 15). However, the relative 
reproducibility is more than 5 of 7. The reason why they show no completely identical result 
is might be originated from the irregularity of F wave. AMAP source localization could not 
acquire identical acquisition of F wave in time, activity intensity, and dispersion. However, the 
F wave source is localized within near location with variant activity. 
8.12 MCG map-guided minimal AF surgery 
 
AMAP map                  Inferred route              Minimal AF surgery (cryo)
Rt Linear + Lt ½ PVI
Case 4. KSA
 
Case 4. 
¬ 46 years old /  Female (Kang S Ae)                                               (April 24, 2007)
¬ Severe MS (MVA 0.91cm2) with moderate MR (jet area 10cm2) due to calcified 
leaflet, mild AR, moderate TR (jet area 10.2cm2), moderate pulmonary HT
¬ LA size 67mm, Ejection fraction 57%
¬ chronic AF which lasts at least 14 days from my ECG
¬ Op : MVR with On-X 33mm
AVP ; three commissural suspension using 5-0 prolene pledget suture
TAP ; DeVega with 3-0 prolene continuous suture
MCG map-guided minimal AF surgery (cryo)
 
Fig. 16. Example of successful MCG map-guided minimal AF surgery. (a) Sequential 3D 
source localization (upper) and schematic view of AMAP map, inferred route and minimal 
AF surgery (lower) (b) Case summery and ECG results, pre and postoperative status. 
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After making the MCG map for AF, AF ablation operation method were planned, such as 
location and length of incision or cryo-ablation, and other combined procedures according 
to the patient’s disease status; atrium size, valve incompetence, coronary artery stenosis, etc. 
Under the institutional ethical review board’s approval, using MCG map, 8 cases of MCG 
map-guided minimal AF surgery were conducted successfully. 46 years-old female patient 
case is shown at fig. 16. There are no sick sinus syndrome, no permanent pacemaker 
insertion, 100% sinus conversion at immediate postoperative time and 5 of 7 reached sinus 
rhythm successfully with drug-off. 
9. Conclusions 
The proposed separative Surface potential activation beamformer (sSPAB) visualized 
successfully the Activity map of action potential (AMAP) corresponding to the F-wave in 
the Magnetocardiography (MCG) records of a patient with AF. In addition, a prompt 
visualization of the electrical excitation of the myocardium is crucial for a clinical 
application of the MCG. By confining the source power calculation of the sSPAB to the 
coordinates on the endocardial and epicardial surfaces, the AMAP could be obtained on the 
heart boundary in a very short time, a couple of minutes. The obtained F-waves show 
periodic oscillatory behaviors. By using the sSPAB, the F-wave was separated from the other 
activations and localized the position of a reentry circuit corresponding to the F-wave. By 
separating the F-wave time-by-time and visualizing the AMAP for each time-separated 
waveform, the propagation trace of the AF was able to be inferred. 
From the reproducibility test of source localization using Equivalent double layer 3D 
method, the result is very similar to each other in different seven records. Map-guided AF 
surgery facilitates less-extensive procedures and has an ultimate benefit to patient. Smaller 
incision, simple minimal procedure, reduced postoperative bleeding, shortened 
cardiopulmonary bypass time, etc could be the advantages of map-guided surgery. MCG is 
a totally noninvasive and even non-contact method for analyzing AF. The visualization of 
the myocardial current distribution corresponding to the reentrant excitation would be a 
great help for planning the AF surgery and the follow-up examination. However, more 
technical development in sensitivity of MCG system and image processing solution are 
required for more accurate source localization and propagation. 
10. Future experimental mappings 
Ideal future mapping methods should offer (i) high sensitivity to detect very small targets, 
(ii) high spatio-temporal resolution to localize precisely and follow a propagation route in 
real-time, (iii) noninvasiveness to allow repeat exam, (iv) personalized anatomical 
information, (v) feasibility in clinical application, (vi) minimal adverse effects including 
radiation hazard. To fulfill these goals, many experimental studies are conducted. Novel 
mapping and imaging technologies such as cardiac MRI, MR spectroscopy, diffused optical 
spectroscopy, optical imaging, cardiac coherence tomography is under development for 
clinical use. 
Optical mapping, cardiac electrical activity mapping using fluorescence imaging techniques 
provides unprecedented details of cardiac electrical activity at high spatial and temporal 
resolution and optical recordings of action potentials with signals similar to the shape and 
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time course of action potentials recorded with intracellular microelectrodes. It can image 
electrical activity at sufficiently fast rates to map rapid activation of cardiac tissue during 
reentry, and provide detailed maps of repolarization sequences. Experimental studies using 
high-resolution optical mapping of impulse propagation during AF in the isolated sheep 
heart demonstrate that acetylcholine (Ach) dose-dependent reentrant sources in the left 
atrium can drive the fibrillatory activity throughout both atria. Using phase representation 
of the local impulse kinetics, Berenfeld et al. [73-74] establish that rotors can arise from 
unidirectional blocks of propagation at functional obstacles. Further spatiotemporal tracking 
of the wavebreak sites identifies a functional isthmus in the wake of such an obstacle whose 
minimal width supporting a figure-of-eight reentry substance is about 4 mm. In the absence 
of Ach, increasing the intra-atrial pressure revealed a consistent increase in the frequency 
and dominance of activation in an area between the atrium and a pulmonary vein with the 
appearance of intermittent reentrant activity there. From the development of molecular 
biology and genetics, channelopathy, disease of structure and function of cardiac ion 
channel, results in atrial tachyarrhythmias. The role of mapping in channelopathies is 
important subjects such as in Brugada syndrome, long-QT syndrome, idiopathic VF, etc. To 
overcome the limitation of current morphological and functional imaging technique, 
molecular cardiovascular imaging with SPECT and PET will be facilitated, which directly 
and noninvasively visualize molecular pathways in normal and diseased condition in vivo. 
 
  
 
  
Fig. 17. Future advancement in mapping including (upper left) personalized 3D atrial 
modeling, (upper right) detailed anatomy information including PA, LAA, etc, (lower) 
detailed endoscopic view. Courtesy from Prof. Eun-Bo Shim and Whal Lee. 
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The role of mapping will be expanded in the fields of early detection of disease, risk 
evaluation, treatment guidance and outcome accessment. In technical viewpoint of mapping 
in AF, (i) personalized 3D atrial modeling, (ii) detailed anatomy information including PA, 
LAA, etc, (iii) detailed endoscopic view, (iv) real-time processing map, and (v) 4D cine-MR 
based map should be made near future (Fig.17). 
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